APO BE 20 (Benazepril 20 mg)
Pill imprint APO BE 20 has been identified as Benazepril hydrochloride 20 mg.
Benazepril is used in the treatment of diabetic kidney disease; high blood pressure; left ventricular dysfunction; heart failure and belongs to the drug class angiotensin converting enzyme inhibitors. There is positive evidence of human fetal risk during pregnancy. Benazepril 20 mg is not a controlled substance under the Controlled Substance Act (CSA).
- Imprint:
- APO BE 20
- Strength:
- 20 mg
- Color:
- Orange
- Size:
- 5.00 mm
- Shape:
- Round
- Availability:
- Prescription only
- Drug Class:
- Angiotensin converting enzyme inhibitors
- Pregnancy Category:
- D - Positive evidence of risk
- CSA Schedule:
- Not a controlled drug
- Manufacturer:
- Apotex Corp.
- National Drug Code (NDC):
- 60505-0267
- Inactive Ingredients:
- silicon dioxide
crospovidone
hydroxypropyl cellulose
hypromellose 2910 (5 mPa.s)
microcrystalline cellulose
polyethylene glycol 8000
titanium dioxide
zinc stearate
ferric oxide red
| NDC Code | Manufacturer / Repackager |
|---|---|
| 43063-0131 | PDRX Pharmaceuticals Inc (repackager) |
Note: Inactive ingredients may vary.
More about benazepril
Consumer resources
- Other brands: Lotensin
Professional resources
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
